◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items
Daito Pharmaceutical Co.,Ltd. — Financial Statements
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line ItemQ1 2026Jan 21, 2026Q1 2026Jan 14, 2026Q1 2025Jan 10, 2025Q2 2024May 31, 2024Q2 2023May 31, 2023Q2 2022May 31, 2022Q2 2021May 31, 2021
+Operating Income 1.5B 1.5B 2.3B -- -- -- --
Operating Margin % 100.1% 100.1% 98.9% -- -- -- --
+Ordinary Income 1.5B 1.5B 2.3B -- -- -- --
Revenue Growth % 0.0% -36.5% -- -- -- -- --
Line ItemQ1 2026Jan 21, 2026Q1 2026Jan 14, 2026Q1 2025Jan 10, 2025Q2 2024May 31, 2024Q2 2023May 31, 2023Q2 2022May 31, 2022Q2 2021May 31, 2021
Current Assets 41.7B 41.7B 41.5B -- -- -- --
Total Assets 78.0B 78.0B 77.7B 71.5B 69.4B 61.0B 57.1B
Current Liabilities 17.0B 17.0B 18.5B -- -- -- --
Total Liabilities 25.9B 25.9B 25.4B 20.2B 20.7B 16.3B 16.4B
Total Equity 52.1B 52.1B 52.3B 51.3B 48.7B 44.6B 40.7B
Equity Ratio -- -- -- 0.71 0.70 0.73 0.71
No data available for this statement.
NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...